journal
MENU ▼
Read by QxMD icon Read
search

Current Heart Failure Reports

journal
https://www.readbyqxmd.com/read/29987499/decompensated-heart-failure-and-renal-failure-what-is-the-current-evidence
#1
REVIEW
Agata Bielecka-Dabrowa, Breno Godoy, Joerg C Schefold, Michael Koziolek, Maciej Banach, Stephan von Haehling
PURPOSE OF REVIEW: Acute decompensated heart failure (ADHF) is one of the biggest challenges in the management of chronic heart failure. Despite several advances in medical and device therapy, high readmission and mortality rates continue to be a burden on healthcare systems worldwide. The aim of the current review is to provide an overview on current as well as future approaches in cardiorenal interactions in patients with ADHF. RECENT FINDINGS: One of the strongest predictors of adverse outcomes in ADHF is renal dysfunction, referred to as cardiorenal syndromes (CRS) or cardiorenal interactions...
July 10, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29987498/the-confounding-effects-of-non-cardiac-pathologies-on-the-interpretation-of-cardiac-biomarkers
#2
REVIEW
Marin Nishimura, Alison Brann, Kay-Won Chang, Alan S Maisel
PURPOSE OF REVIEW: Cardiac biomarkers play important roles in routine evaluation of cardiac patients. But while these biomarkers can be extremely valuable, none of them should ever be used by themselves-without adding the clinical context. This paper explores the non-cardiac pathologies that can be seen with the cardiac biomarkers most commonly used. RECENT FINDINGS: High-sensitivity troponin assay gained FDA approval for use in the USA, and studies demonstrated its diagnostic utility can be extended to patients with renal impairment...
July 10, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29971612/the-effect-of-left-ventricular-assist-device-therapy-on-cardiac-biomarkers-implications-for-the-identification-of-myocardial-recovery
#3
REVIEW
Luise Holzhauser, Gene Kim, Gabriel Sayer, Nir Uriel
PURPOSE OF REVIEW: Left ventricular assist device (LVAD) therapy serves as mainstay therapy for bridge to transplantation and destination therapy. Evidence is now mounting on the role of LVAD therapy as bridge to recovery. In the current review, we will summarize the data on biomarkers of myocardial recovery following LVAD implantation. RECENT FINDINGS: Myocardial recovery can occur spontaneously, following pharmacological intervention and in the setting of mechanical circulatory support such as LVAD...
July 3, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29959688/identifying-and-managing-hibernating-myocardium-what-s-new-and-what-remains-unknown
#4
REVIEW
Matthew J Ryan, Divaka Perera
PURPOSE OF REVIEW: Hibernation is an important and reversible cause of myocardial dysfunction in ischaemic heart failure. RECENT FINDINGS: Hibernation is an adaptive process that promotes myocyte survival over maintaining contractile function. It is innate to mammalian physiology, sharing features with physiological hibernation in other species. Advanced imaging methods have reasonable accuracy in identifying hibernating myocardium. Novel superior hybrid methods may provide diagnostic potential...
June 29, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29951883/pharmacologic-management-of-cancer-therapeutics-induced-cardiomyopathy-in-adult-cancer-survivors
#5
REVIEW
J Emanuel Finet, Gregory A Wiggers
PURPOSE OF REVIEW: The number of cancer survivors is exponentially increasing worldwide, due to both advances in cancer detection and treatment strategies, as well as the aging and growth of the population. This decrease in cancer mortality has brought forth a concurrent increase of non-ischemic (toxic) dilated cardiomyopathy in the survivor population, also known as cancer therapeutics-induced cardiomyopathy (CTIC). The optimal pharmacological management for this condition is still elusive, and hence, the focus of this work...
June 27, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29943347/complicated-acute-heart-failure-subsets
#6
REVIEW
Prithwish Banerjee
No abstract text is available yet for this article.
June 26, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29938322/decompensated-heart-failure-with-ventricular-arrhythmia-how-useful-is-vt-ablation
#7
REVIEW
Gerasimos Dimitropoulos, Georgios Leventogiannis, Joseph De Bono
PURPOSE OF REVIEW: Ventricular arrhythmias are common in patients with heart failure. Their management especially in the context of decompensated heart failure poses a clinical challenge to modern cardiologists. In this review article, we aim to summarise the current evidence on the epidemiology, pathophysiology, and management of ventricular tachycardia in heart failure, focusing primarily on the use of catheter ablation. RECENT FINDINGS: The evolution of electro-anatomical mapping techniques and ablation catheter technology in the recent years has paved the path for the successful application of catheter ablation in the treatment of ventricular arrhythmias...
June 25, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29938321/prevention-of-cardiotoxicities-with-traditional-and-novel-chemotherapeutic-agents
#8
REVIEW
Zarina Sharalaya, Patrick Collier
PURPOSE OF REVIEW: This review will discuss strategies to prevent cardiotoxicity associated with chemotherapeutics. Forty years ago, investigators identified dose-dependent cardiotoxicity related to anthracycline-based regimens. Over recent decades, the development of more selective, mechanism-based chemotherapeutics has been associated with both on-target and off-target adverse cardiovascular sequelae. RECENT FINDINGS: Strategies to prevent or attenuate cardiotoxicities include limitation of anthracycline dose, appropriate patient selection, referral/access to cardio-oncology programs, early recognition of cardiac side effects, active cardio-surveillance, cardio-protective medical therapy, treatment-specific concerns, and follow-up...
June 25, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29744760/correction-to-vitamin-d-and-heart-failure
#9
D Marshall Brinkley, Omair M Ali, Sandip K Zalawadiya, Thomas J Wang
The original version of this article, published in Current Heart Failure Reports, Volume 14, Issue 5, October 2017, erroneously cited an author's name as Marshall Brinkley, D" when it should be "Brinkley, DM."
April 30, 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29707741/myocardial-energetics-and-heart-failure-a-review-of-recent-therapeutic-trials
#10
REVIEW
Kunal N Bhatt, Javed Butler
PURPOSE OF REVIEW: Several novel therapeutics being tested in patients with heart failure are based on myocardial energetics. This review will provide a summary of the recent trials in this area, including therapeutic options targeting various aspects of cellular and mitochondrial metabolism. RECENT FINDINGS: Agents that improve the energetic balance in myocardial cells have the potential to improve clinical heart failure status. The most promising therapies currently under investigation in this arena include (1) elamipretide, a cardiolipin stabilizer; (2) repletion of iron deficiency with intravenous ferrous carboxymaltose; (3) coenzyme Q10; and (4) the partial adenosine receptor antagonists capadenoson and neladenosone...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29700697/essential-elements-of-early-post-discharge-care-of-patients-with-heart-failure
#11
REVIEW
Richard J Soucier, P Elliott Miller, Joseph J Ingrassia, Ralph Riello, Nihar R Desai, Tariq Ahmad
PURPOSE OF REVIEW: Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Several national policy initiatives have focused on improving the quality of heart failure care, including reducing readmissions following hospitalization, which are common, costly, and, at least in part, preventable. The transition from inpatient to ambulatory care setting and the immediate post-hospitalization period present an opportunity to further optimize guideline concordant medical therapy, identify reversible issues related to worsening heart failure, and evaluate prognosis...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29667071/optimizing-cardiac-resynchronization-therapy-an-update-on-new-insights-and-advancements
#12
REVIEW
Adam Grimaldi, Eiran Z Gorodeski, John Rickard
PURPOSE OF REVIEW: This review focuses on the current advancements in optimizing patient response to cardiac resynchronization therapy (CRT). RECENT FINDINGS: It has been well known that not every patient will derive benefit from CRT, and of those that do, there are varying levels of response. Optimizing CRT begins well before device implant and involves appropriate patient selection and an understanding of the underlying substrate. After implant, there are different CRT device programming options that can be enabled to help overcome barriers as to why a patient may not respond...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29629485/has-the-time-come-to-be-more-aggressive-with-bariatric-surgery-in-obese-patients-with-chronic-systolic-heart-failure
#13
REVIEW
Amanda R Vest
PURPOSE OF REVIEW: Obesity is a strong risk factor for the development of heart failure (HF). Diet, exercise, and weight-loss pharmacotherapies have limited potential to achieve significant and sustainable weight loss, especially in patients with symptomatic systolic HF. This review seeks to determine the role of bariatric surgery for patients with systolic HF and obesity. RECENT FINDINGS: Bariatric surgeries such as the laparoscopic sleeve gastrectomy (LSG) and Roux-en-Y gastric bypass (RYGB) represent the most successful long-term strategy for achieving weight loss and diabetes and hypertension remission in the general obese population...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29623530/novel-insights-and-treatment-strategies-for-right-heart-failure
#14
REVIEW
Weiqin Lin, Ai-Ling Poh, W H Wilson Tang
PURPOSE OF REVIEW: The function of the right ventricle (RV) is intimately linked to its preload (systemic volume status) and afterload (pulmonary vasculature). In this review, we explore current knowledge in RV physiology, RV function assessment, causes of right heart failure (RHF), and specific treatment strategies for RHF. RECENT FINDINGS: We examine the evidence behind new pharmacological therapies available, such as macitentan and riociguat in the treatment of specific etiologies of RHF...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29623529/nutritional-interventions-in-heart-failure-challenges-and-opportunities
#15
REVIEW
Conor P Kerley
PURPOSE OF REVIEW: There is a growing body of evidence that nutritional factors influence the incidence of heart failure (HF). The current manuscript aims to collate evidence relating to nutritional intervention in the treatment of HF as well as to provide context regarding challenges and opportunities in the field. RECENT FINDINGS: Despite the accepted importance of nutritional factors relating to cardiovascular disease severity, there is surprisingly little human intervention research regarding dietary intake and HF...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29616492/contraceptive-strategies-in-women-with-heart-failure-or-with-cardiac-transplantation
#16
REVIEW
Anjli Maroo, Johnny Chahine
PURPOSE OF REVIEW: We describe contraception for two groups of women: (1) women with heart failure and (2) women with cardiac transplantation. RECENT FINDINGS: Medical Eligibility Criteria for contraceptive agents address women with peripartum cardiomyopathy and women with valvular heart disease (Curtis et al. MMWR Recomm Rep 65:1-103, 2016). Recommendations for women with other forms of heart failure are extrapolated from these populations. Recommendations for women with cardiac transplantation have shifted since the 1980s: use of long-acting reversible contraception has increased, and there is a better understanding of the interactions between contraceptive and immunosuppressive regimens...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29616491/management-of-sleep-disordered-breathing-in-patients-with-heart-failure
#17
REVIEW
Connor P Oates, Manjula Ananthram, Stephen S Gottlieb
PURPOSE OF REVIEW: This paper reviews treatment options for sleep disordered breathing (SDB) in patients with heart failure. We sought to identify therapies for SDB with the best evidence for long-term use in patients with heart failure and to minimize uncertainties in clinical practice by examining frequently discussed questions: what is the role of continuous positive airway pressure (CPAP) in patients with heart failure? Is adaptive servo-ventilation (ASV) safe in patients with heart failure? To what extent is SDB a modifiable risk factor? RECENT FINDINGS: Consistent evidence has demonstrated that the development of SDB in patients with heart failure is a poor prognostic indicator and a risk factor for cardiovascular mortality...
June 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29520707/biomarkers-of-cardiac-stress-and-injury-in-athletes-what-do-they-mean
#18
REVIEW
Eoin Donnellan, Dermot Phelan
PURPOSE OF THE REVIEW: Markers of myocardial stress, including troponin, creatine kinase, and brain natriuretic peptide are frequently elevated after endurance athletic pursuits. Here, we summarize the current literature pertaining to the potential mechanism of cardiac enzyme release in athletes and seek to determine the clinical implications of these findings. RECENT FINDINGS: Recent studies have highlighted the potential adverse cardiac effects of long-term extreme endurance exercise...
April 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29520706/the-evolving-role-of-cardiorespiratory-fitness-and-exercise-in-prevention-and-management-of-heart-failure
#19
REVIEW
Wally Omar, Ambarish Pandey, Mark J Haykowsky, Jarett D Berry, Carl J Lavie
PURPOSE OF REVIEW: This paper highlights the dynamic relationship between cardiorespiratory fitness (CRF) and heart failure (HF). As heart failure with preserved ejection fraction (HFpEF) surpasses heart failure with reduced ejection fraction (HFrEF) in prevalence, our void in understanding how to treat this syndrome becomes less justifiable. As such, significant attention has been given to the role that obesity and physical inactivity play, as both risk factors for heart failure, and therapeutic targets for its treatment...
April 2018: Current Heart Failure Reports
https://www.readbyqxmd.com/read/29480349/fill-in-the-gaps-of-secondary-mitral-regurgitation-a-continuum-challenge-from-pathophysiology-to-prognosis
#20
REVIEW
Riccardo M Inciardi, Andrea Rossi, Giovanni Benfari, Mariantonietta Cicoira
PURPOSE OF REVIEW: Mitral regurgitation (MR) is one of the most frequent valvular heart diseases encountered in clinical practice. In contrast to primary MR, less is still known about the pathophysiology, diagnosis, and prognosis of secondary MR. The purpose of this report is to provide a review, upon the last knowledge reported in the literature, on the role and management of secondary MR in clinical practice. RECENT FINDINGS: Recent data highlight secondary MR not as a single pathological entity but as a wide spectrum of interconnected conditions which portend poor outcome...
April 2018: Current Heart Failure Reports
journal
journal
40571
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"